Asthma management guidelines
Executive Summary
Draft report of the National Heart, Lung and Blood Institute's National Asthma Education Program Coordinating Committee recommends that asthma patients receive cromolyn or a topical steroid, as well as a bronchodilator, during initial treatment. Committee member Albert Sheffer, MD, Harvard Medical School, presented an overview of the draft report at a June 8 meeting of the committee. Noting that there are "better topical steroids on the continent" than in the U.S., Sheffer decried the "steroid phobia" in the U.S. The final report on asthma management is to be completed by Nov. 2.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.